These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1689569)

  • 1. Tumor necrosis factor antagonizes inhibitory effect of azidothymidine on human immunodeficiency virus (HIV) replication in vitro.
    Ito M; Baba M; Mori S; Hirabayashi K; Sato A; Shigeta S; De Clercq E
    Biochem Biophys Res Commun; 1990 Feb; 166(3):1095-101. PubMed ID: 1689569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus type 1 (HIV-1) inhibitory interactions between protease inhibitor Ro 31-8959 and zidovudine, 2',3'-dideoxycytidine, or recombinant interferon-alpha A against zidovudine-sensitive or -resistant HIV-1 in vitro.
    Johnson VA; Merrill DP; Chou TC; Hirsch MS
    J Infect Dis; 1992 Nov; 166(5):1143-6. PubMed ID: 1328402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic inhibition of replication of human immunodeficiency virus type 1, including that of a zidovudine-resistant isolate, by zidovudine and 2',3'-dideoxycytidine in vitro.
    Eron JJ; Johnson VA; Merrill DP; Chou TC; Hirsch MS
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1559-62. PubMed ID: 1324648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor enhances replication of human immunodeficiency virus (HIV) in vitro.
    Ito M; Baba M; Sato A; Hirabayashi K; Tanabe F; Shigeta S; De Clercq E
    Biochem Biophys Res Commun; 1989 Jan; 158(1):307-12. PubMed ID: 2912452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by recombinant soluble CD4 and 3'-azido-3'-deoxythymidine.
    Johnson VA; Barlow MA; Chou TC; Fisher RA; Walker BD; Hirsch MS; Schooley RT
    J Infect Dis; 1989 May; 159(5):837-44. PubMed ID: 2785146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of RP 55778, a tumor necrosis factor alpha synthesis inhibitor, on antiviral activity of dideoxynucleosides.
    Clayette P; Dereuddre-Bosquet N; Martin M; Fretier P; Dormont D
    Antimicrob Agents Chemother; 1997 Apr; 41(4):875-7. PubMed ID: 9087512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological comparison of wild-type and zidovudine-resistant isolates of human immunodeficiency virus type 1 from the same subjects: susceptibility and resistance to other drugs.
    Rooke R; Parniak MA; Tremblay M; Soudeyns H; Li XG; Gao Q; Yao XJ; Wainberg MA
    Antimicrob Agents Chemother; 1991 May; 35(5):988-91. PubMed ID: 1649576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative.
    Baba M; Tanaka H; De Clercq E; Pauwels R; Balzarini J; Schols D; Nakashima H; Perno CF; Walker RT; Miyasaka T
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1375-81. PubMed ID: 2575380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.
    Granowitz EV; Saget BM; Wang MZ; Dinarello CA; Skolnik PR
    Mol Med; 1995 Sep; 1(6):667-77. PubMed ID: 8529133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
    Perno CF; Yarchoan R; Cooney DA; Hartman NR; Gartner S; Popovic M; Hao Z; Gerrard TL; Wilson YA; Johns DG
    J Exp Med; 1988 Sep; 168(3):1111-25. PubMed ID: 2844951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell specific uptake of antiretroviral drugs: AZT coupled to LDL inhibits HIV replication in human macrophages.
    Mankertz J; von Baeyer H; Rokos K; Nündel M; Pauli G; Riedel E
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):85-8. PubMed ID: 7757316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages.
    Mellors JW; Griffith BP; Ortiz MA; Landry ML; Ryan JL
    J Infect Dis; 1991 Jan; 163(1):78-82. PubMed ID: 1984479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of azidothymidine to inhibit human immunodeficiency virus (HIV) replication in a promonocytic cell line (U937).
    Uherová P; Schmidtmayerová H; Mayer V
    Acta Virol; 1991 Aug; 35(4):357-64. PubMed ID: 1724875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential alteration of the anti-HIV-1 effect of phosphorothioate oligonucleotide S-dC28 by AZT, interferon-alpha, and dextran sulfate.
    Chou TC; Zhu QY; Stein CA
    AIDS Res Hum Retroviruses; 1991 Nov; 7(11):943-51. PubMed ID: 1760231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HIV activity of dextran sulphate as determined under different experimental conditions.
    Nakashima H; Yoshida O; Baba M; De Clercq E; Yamamoto N
    Antiviral Res; 1989; 11(5-6):233-46. PubMed ID: 2478075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased therapeutic efficacy of zidovudine in combination with vitamin E.
    Gogu SR; Beckman BS; Rangan SR; Agrawal KC
    Biochem Biophys Res Commun; 1989 Nov; 165(1):401-7. PubMed ID: 2590237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): enhancement of HIV replication.
    Matsuyama T; Hamamoto Y; Soma G; Mizuno D; Yamamoto N; Kobayashi N
    J Virol; 1989 Jun; 63(6):2504-9. PubMed ID: 2470917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.
    De Clercq E; Yamamoto N; Pauwels R; Baba M; Schols D; Nakashima H; Balzarini J; Debyser Z; Murrer BA; Schwartz D
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5286-90. PubMed ID: 1608936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of human immunodeficiency virus replication by azidothymidine (Azitidín Lachema) in cultured cells].
    Schmidtmayerová H; Mayer V
    Bratisl Lek Listy; 1993 Feb; 94(2):76-80. PubMed ID: 7689030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary evidence that azidothymidine does not affect hepatitis B virus replication in acquired immunodeficiency syndrome (AIDS) patients.
    Farraye FA; Mamish DM; Zeldis JB
    J Med Virol; 1989 Dec; 29(4):266-7. PubMed ID: 2621453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.